New Therapy in Pulmonary Fibrosis CCR6 Mediates CCL18 Induced Fibrosis and EMT Technology CCL18 is a chemokine released by alternatively activated macrophages. We have recently documented that serum CCL18 concentrations

First Page		Document Content
Date: 2015-02-19 08:11:00 Anatomy CCL18 Usual interstitial pneumonia Idiopathic pulmonary fibrosis Chemokine Interstitial lung disease C-C chemokine receptor type 6 Non-small-cell lung carcinoma Pulmonary fibrosis Biology Lung Cytokines		New Therapy in Pulmonary Fibrosis CCR6 Mediates CCL18 Induced Fibrosis and EMT Technology CCL18 is a chemokine released by alternatively activated macrophages. We have recently documented that serum CCL18 concentrations Add to Reading List Source URL: www.campus-technologies.de Download Document from Source Website File Size: 1,32 MB Share Document on Facebook

	CURRENT UPDATES ON PA T H O L O G Y O F LUNG TUMORS DocID: 1vn7k - View Document
	WSCConference 16 Case 1 – Tissue from a green tree python. MICROSCOPIC DESCRIPTION: Lung(1pt): Faveolar septa are markedly expanded up to 300um. (1pt)There is marked diffuse disorganized (1pt) hyperplasia (1 DocID: 1vmse - View Document
	Journal of Infection and Public Health, S31—S34 EGFR mutation testing in non-small cell lung cancer (NSCLC) Fouad Al Dayel 1 Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital an DocID: 1vjEy - View Document
	RESEARCH Efficacy, safety and economy of icotinib for advanced non-small cell lung cancer: a meta-analysis DocID: 1vfqs - View Document
	2017 Acknowledgments The American Lung Association “State of the Air® 2017” is the result of the hard work of many people: DocID: 1vaRd - View Document